Sunday, December 11, 2005

Lybrel (Anya)

Good news about Lybrel, Wyeth's new continuous, low-dose (20 mcg ethinyl estradiol/90 mcg levonorgestrel) birth control pill. Lybrel, designed to be taken daily with no hormone-free intervals, showed complete ovulation suppression in a small study, and significant control of premenstrual symptoms in a larger, but not placebo controlled, study:

One study, involving 37 women aged 18-35 years, showed complete inhibition of ovulation in all women while on the oral formulation.

"We showed that none of the subjects developed follicles equal to or greater than 10 mm during treatment,"; said investigator Susan A. Ballagh, M.D., of the Contraceptive Research and Development program, Arlington, Va., of the Eastern Virginia Medical School, Norfolk.

Participants followed the continuous oral contraception (COC) regimen for 84 days, using three pill-pack segments.

After discontinuation of contraception, the time to return to normal ovulation--defined as serum progesterone levels greater than 5 ng/mL--was a mean of 20 days. A total of 95% of subjects ovulated within 25 days after discontinuation.


The second study found that the same COC regimen significantly alleviated premenstrual symptoms.

A total of 278 women with a history of cycle-related symptoms or dysmenorrhea were monitored during three cycles of the COC regimen, with no pill-free interval. The subjects maintained a daily diary, rating mood, behavior, pain, and physical symptoms using the Penn Daily Symptom Rating scale. Two-thirds of the women improved their scores by 50% in the first 28-day cycle (one pill pack). In addition, work productivity improved.

"What impressed me the most was the very immediate response of the first cycle and the strong response at end point," said lead investigator Ellen Freeman, Ph.D., of the University of Pennsylvania in Philadelphia. "Almost all the response occurred right away. That's fast. Secondly, I was surprised that all four of the symptom subscales seemed to respond similarly."

More from Wyeth here.

ETA: It appears the brand name in Canada and the EU will be Anya.


At 6:41 AM, Blogger linalone said...

HI, I would like to know when it will be commercialised in the Middle East and under which Brand Name?

At 2:17 PM, Anonymous Anonymous said...

And the point of me suppressing my biological, bodily functions would be? Also, I'd like to know when Wyeth will come out with a way to suppress sweating, urinating, and defecating.

At 9:31 PM, Blogger Kate said...

Hey, I'd like to know when it will be commercialised in the UK, and also under which Brand Name? Thanks.

At 7:56 PM, Blogger Jason said...

Hi, this product will probably be commercialized in the Middle East in 250-1000 years, judging by how they catch up with the rest of the world. Look for it then.

At 7:30 PM, Anonymous Alex said...

Lybrel will be marketed as Anya outside of the U.S. and it should be available this year (this month in the US)

At 9:03 AM, Anonymous Anonymous said...

it is very well available in US and Canada. I came across the site from where you can place order. It could be possible that you may order from Middle East and they will dispatch your medicines.

At 4:34 PM, Anonymous Anonymous said...

will taking this have an adverse effect on Bone mineral density?

At 9:27 AM, Anonymous Anonymous said...

OMG OMG i want this pill...... i HATE periods they are so horrible and just undignified... whoever invented this is a fking genius.


Post a Comment

Links to this post:

Create a Link

<< Home